Cognitive and executive dysfunctions in cocaine dependence: A case-control study;Alteraciones de funciones cognitivas y ejecutivas en pacientes dependientes de cocaína: Estudio de casos y controles

Revista de Neurologia

Volumn 54, Issue 4, 2012, Pages 199-208

  Madoz Gúrpide, Agustín ^a   Ochoa Mangado, Enriqueta ^b  

^a Centro de Salud Mental San Blas   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Cocaine; Cognitive development; Ecological test; Evaluation; Executive functioning; Neuropsychological impairment

Indexed keywords

ALCOHOL CONSUMPTION; ARTICLE; CARDS TEST; CASE CONTROL STUDY; COCAINE DEPENDENCE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; EXECUTIVE FUNCTION; FINGER SPAN TEST; GENDER; HUMAN; MENTAL PERFORMANCE; NEUROPSYCHOLOGICAL TEST; OBSERVATIONAL STUDY; RACE; SCHOOL; WISCONSIN CARD SORTING TEST; ZOO MAP TEST;

EID: 84857187213     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.5404.2011174     Document Type: Article

References (55)

1. Oficina de las Naciones Unidas contra la Droga y el Delito. Informe mundial sobre las drogas 2010. Vienna: UNODC; 2010. URL: http://www.unodc.org/documents/wdr/WDR_2010/World_Drug_Report_2010_lo-res.pdf. [15.03.2011].
2. Volkow ND, Fowler JS. Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereb Cortex 2000; 10: 318-25.
3. Fowler JS, Volkow ND, Wang GJ, Gatley SJ, Logan J. Cocaine: PET studies of cocaine pharmacokinetics, dopamine transporter availability and dopamine transporter occupancy. Nucl Med Biol 2001; 28: 561-72.
4. Aron JL, Paulus MP. Location, location: using functional magnetic resonance imaging to pinpoint brain differences relevant to stimulant use. Addiction 2007; 102 (Suppl 1): 33-43.
5. Tomasi D, Volkow ND, Wang R, Carrillo JH, Maloney T, Alia-Klein N, et al. Disrupted functional connectivity with dopaminergic midbrain in cocaine abusers. PLoS One 2010; 25: e10815.
6. Witten IA, Lin SC, Brodsky M, Prakash R, Diester I, Anikeeva P, et al. Cholinergic interneurons control local circuit activity and cocaine conditioning. Science Express 2010; 330: 1677-81.
7. Lezak MD, Howieson DB, Loring DW. Neuropsychological assessment. 4 ed. New York: Oxford University Press; 2004.
8. Tirapu-Ustárroz J, García-Molina A, Luna-Lario P, Roig-Rovira T, Pelegrín-Valero C. Modelos de funciones y control ejecutivo (I). Rev Neurol 2008; 46: 684-92.
9. Tirapu-Ustárroz J, García-Molina A, Luna-Lario P, Roig-Rovira T, Pelegrín-Valero C. Modelos de funciones y control ejecutivo (II). Rev Neurol 2008; 46: 742-50.
10. Horner MD. Attentional functioning in abstinent cocaine abusers. Drug Alcohol Depend 1999; 54: 19-33.
11. Bolla KI, Funderburk FR, Cadet JL. Differential effects of cocaine and cocaine alcohol on neurocognitive performance. Neurology 2000; 54: 2285-92.
12. Aharonovich E, Nunes E, Hasin D. Cognitive impairment, retention and abstinence among cocaine abusers in cognitivebehavioral treatment. Drug Alcohol Depend 2003; 71: 207-11.
13. Cunha PJ, Nicastri S, Gomes LP, Moino RM, Peluso MA. Neuropsychological impairments in crack cocaine-dependent inpatients: preliminary findings. Rev Bras Psiquiatr 2004; 26: 103-6.
14. Bolla K, Ernst M, Kiehl K, Mouratidis M, Eldreth D, Contoreggi C, et al. Prefrontal cortical dysfunction in abstinent cocaine abusers. J Neuropsychiatry Clin Neurosci 2004; 16: 456-64.
15. Aharonovich E, Hasin DS, Brooks AC, Liu X, Bisaga A, Nunes EV. Cognitive deficits predict low treatment retention in cocaine dependent patients. Drug Alcohol Depend 2006; 81: 313-22.
16. Streeter CC, Terhune DB, Whitfield TH, Gruber S, Sarid-Segal O, Silveri MM, et al. Performance on the Stroop predicts treatment compliance in cocaine-dependent individuals. Neuropsychopharmacology 2008; 33: 827-36.
17. Turner TH, LaRowe S, Horner MD, Herron J, Malcolm R. Measures of cognitive functioning as predictors of treatment outcome for cocaine dependence. J Subst Abuse Treat 2009; 37: 328-34.
18. Jovanovski D, Erb S, Zakzanis KK. Neurocognitive deficits in cocaine users: a quantitative review of the evidence. J Clin Exp Neuropsychol 2005; 27: 189-204.
19. Goldstein RZ, Leskovjan AC, Hoff AL, Hitzemann R, Bashan F, Khalsa SS, et al. Severity of neuropsychological impairment in cocaine and alcohol addiction: association with metabolism in the prefrontal cortex. Neuropsychologia 2004; 42: 1447-58.
20. Abi-Saab D, Beauvais J, Mehm J, Brody M, Gottschalk C, Kosten TR. The effect of alcohol on the neuropsychological functioning of recently abstinent cocaine-dependent subjects. Am J Addict 2005; 14: 166-78.
21. Kübler A, Murphy K, Garavan H. Cocaine dependence and attention switching within and between verbal and visuospatial working memory. Eur J Neurosci 2005; 21: 1984-92.
22. Pace-Schott EF, Morgan PT, Malison RT, Hart CL, Edgar C, Walker M, et al. Cocaine users differ from normal on cognitive tasks which show poorer performance during drug abstinence. Am J Drug Alcohol Abuse 2008; 34: 109-21.
23. Garavan H, Kaufman JN, Hester R. Acute effects of cocaine on the neurobiology of cognitive control. Philos Trans R Soc Lond B Biol Sci 2008; 363: 3267-76.
24. Woicik PA, Moeller SJ, Alia-Klein N, Maloney T, Lukasik TM, Yeliosof O, et al. The neuropsychology of cocaine addiction: recent cocaine use masks impairment. Neuropsychopharmacology 2009; 34: 1112-22.
25. Ruiz-Sánchez de León JM, Pedrero-Pérez E, Llanero-Luque M, Rojo-Mota G, Olivar-Arroyo A, Bouso-Saiz JC, et al. Perfil neuropsicológico en la adicción a la cocaína: consideraciones sobre el ambiente social próximo de los adictos y el valor predictivo del estado cognitivo en el éxito terapéutico. Adicciones 2009; 21: 119-32.
26. Browndyke JN, Tucker KA, Woods SP, Beauvals J, Cohen RA, Gottschalk PC, et al. Examining the effect of cerebral perfusion abnormality magnitude on cognitive performance in recently abstinent chronic cocaine abusers. J Neuroimaging 2004; 14: 162-9.
27. Colzato LS, Huizinga M, Hommel B. Recreational cocaine polydrug use impairs cognitive flexibility but not working memory. Psychopharmacology 2009; 227: 225-34.
28. Franken IH, Van Strien JW, Franzek EJ, Van de Wetering BJ. Error-processing deficits in patients with cocaine dependence. Biol Psychol 2007; 75: 45-51.
29. Verdejo-García A, Pérez-García M. Profile of executive deficits in cocaine and heroin polysubstance users: common and differential effects on separate executive components. Psychopharmacology (Berl) 2007; 190: 517-30.
30. Fernández-Serrano MJ, Pérez-García M, Perales JC, Verdejo-García A. Prevalence of executive dysfunction in cocaine, heroin and alcohol users enrolled in therapeutic communities. Eur J Pharmacol 2010; 626: 104-12.
31. Fillmore MT, Rush CR. Impaired inhibitory control of behavior in chronic cocaine users. Drug Alcohol Depend 2002; 66: 265-73.
32. Verdejo A, Orozco-Giménez C, Meersmans Sánchez-Jofre M, Aguilar de Arcos F, Pérez-García M. Impacto de la gravedad del consumo de drogas de abuso sobre distintos componentes de la función ejecutiva. Rev Neurol 2004; 38: 1109-16.
33. Hester R, Garavan H. Executive dysfunction in cocaine addiction: evidence for discordant frontal, cingulate, and cerebellar activity. J Neurosci 2004; 24: 11017-22.
34. Verdejo-García AJ, López-Torrecillas F, Aguilar DA, Pérez-García M. Differential effects of MDMA, cocaine, and cannabis use severity on distinctive components of the executive functions in polysubstance users: a multiple regression analysis. Addict Behav 2005; 30: 89-101.
35. Hester R, Simoes-Franklin C, Garavan H. Post-error behavior in active cocaine users: poor awareness of errors in the presence of intact performance adjustments. Neuropsychopharmacology 2007; 32: 1974-84.
36. García-Fernández G, García-Rodríguez O, Secades-Villa R, Álvarez-Carriles J, Sánchez-Hervás E. Rendimiento neuropsicológico de pacientes en tratamiento por adicción a la cocaína. Salud Drogas 2008; 8: 11-28.
37. Verdejo A, Bechara A, Recknor EC, Pérez-García M. Executive dysfunction in substance dependent individuals during drug use and abstinence: an examination of the behavioral, cognitive and emotional correlates of addiction. J Int Neuropsychol Soc 2006; 12: 405-15.
38. Goldstein RZ, Alia-Klein N, Tomasi D, Zhang L, Cottone LA, Maloney T, et al. Is decreased prefrontal cortical sensitivity to monetary reward associated with impaired motivation and self-control in cocaine addiction? Am J Psychiatry 2007; 164: 43-51.
39. Madoz-Gúrpide A, Blasco-Fontecilla H, Baca-García E, Ochoa-Mangado E. Executive dysfunction in chronic cocaine users: an exploratory study. Drug Alcohol Depend 2011; 117: 55-8.
40. Yücel M, Lubman DI. Neurocognitive and neuroimaging evidence of behavioural dysregulation in human drug addiction: implications for diagnosis, treatment and prevention. Drug Alcohol Rev 2007; 26: 33-9.
41. Ramos-Cejudo J, Irurrizaga-Díez I. Correlatos neuropsicológicos y emocionales implicados en el consumo de cocaína: una revisión teórica a los nuevos hallazgos. Intervención Psicosocial 2009; 18: 245-53.
42. Madoz-Gúrpide A, Ochoa-Mangado E, Martínez-Pelegrín B. Consumo de cocaína y daño neuropsicológico. Implicaciones clínicas. Med Clín (Barc) 2009; 132: 555-9.
43. Lorea I, Fernández-Montalvo J, Tirapu-Ustárroz J, Landa a N, López-Goñi JJ. Rendimiento neuropsicológico en la adicción a la cocaína: una revisión crítica. Rev Neurol 2010; 51: 412-26.
44. Di Sclafani V, Tolou-Shams M, Price LJ, Fein G. Neuropsychological performance of individuals dependent on crackcocaine, or crack-cocaine and alcohol, at 6 weeks and 6 months of abstinence. Drug Alcohol Depend 2002; 66: 161-71.
45. De Oliveira LG, Barroso LP, Silveira CM, Sánchez ZV, De Carvalho Ponce J, Vaz LJ, et al. Neuropsychological assessment of current and past crack cocaine users. Subst Use Misuse 2009; 44: 1941-57.
46. Llanero-Luque M, Ruiz-Sánchez de León JM, Pedrero-Pérez EJ, Olivar-Arroyo A, Bouso-Saiz JC, Rojo-Mota G, et al. Sintomatología disejecutiva en adictos a sustancias en tratamiento mediante la versión española del cuestionario disejecutivo (DEX-Sp). Rev Neurol 2008; 47: 457-63.
47. Pedrero-Pérez EJ, Ruiz-Sánchez de León JM, Llanero-Luque L, Rojo-Mota G, Olivar-Arroyo A, Puerta-García C. Sintomatología frontal en adictos a sustancias en tratamiento mediante la versión española de la escala de comportamiento frontal. Rev Neurol 2009; 48: 624-31.
48. Mintzer MZ, Stitzer ML. Cognitive impairment in methadone maintenance patients. Drug Alcohol Depend 2002; 67: 41-51.
49. Verdejo-García AJ, Perales JC, Pérez-García M. Cognitive impulsivity in cocaine and heroin polysubstance abusers. Addict Behav 2007; 32: 950-66.
50. Ryan JJ, Arb JD, Paul CA, Kreiner DS. Reliability of the WAIS-III subtests, indexes, and IQs in individuals with substance abuse disorders. Assessment 2000; 7: 151-6.
51. Barry D, Petry NM. Predictors of decision-making on the Iowa Gambling Task: independent effects of lifetime history of substance use disorders and performance on the Trail Making Test. Brain Cogn 2008; 66: 243-52.
52. Wilson BA, Alderman N, Burgess PW, Emslie H, Evans JJ. Behavioral assessment of the dysexecutive syndrome. Bury St. Edmunds, UK: Thames Valley Test; 1996.
53. Kamei S, Hara M, Serizawa K, Murakami M, Mizutani T, Ishiburo M, et al. Executive dysfunction using behavioral assessment of the dysexecutive syndrome in Parkinson's disease. Mov Disord 2008; 23: 566-73.
54. Chou LN, Kuo PH, Lin CC, Chen WJ. Genetic and environmental influences on the Wisconsin Card Sorting Test performance in healthy adolescents: a twin/sibling study. Behav Genet 2010; 40: 22-30.
55. Feldstein SN, Keller FR, Portman RE, Durham RL, Klebe KJ, Davis HP. A comparison of computerized and standard versions of the Wisconsin Card Sorting Test. Clin Neuropsychol 1999; 13: 303-13.